Graham Defries Bio

Graham Defries is a partner in the firm’s Life Sciences group, and co-chair of the Life Sciences M&A practice. Graham advises biotech companies, pharmaceutical companies and investors in the life science sector on private equity and venture capital investments/exits, M&A, IPOs, and collaboration/licensing transactions. Graham has been consistently recognized as a leading individual for Life Sciences: Transactional for the past 15 years by Chambers & Partners UK. Graham is recommended by the Legal 500 UK 2025 for M&A and Life Sciences & Healthcare. Clients note that Graham is ‘simply the best. He is sharp, reads the room well, hugely experienced and advises clients on all aspects of the transaction.’ Graham is also ranked in the 2022 edition of IFLR1000 for M&A in the pharmaceutical and life sciences sectors. Prior to joining Goodwin in 2018, Graham was the head of the London life sciences practice at Dechert LLP.